Core A: Administrative Core

核心A:行政核心

基本信息

  • 批准号:
    10708573
  • 负责人:
  • 金额:
    $ 13.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-08-28 至 2028-06-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY The Administrative Core aims to provide executive oversight and administrative support for all SPORE in Pancreatic Cancer projects and cores. The Administrative Core will monitor the activities of all program components, ensure compliance with local and federal grant administration guidelines, and facilitate communication and collaboration among program members. The specific aims of the Administrative Core are: Aim 1: Facilitate intra- and inter-SPORE communication, collaboration, and meetings. This core will be responsible for distributing SPORE-related materials, agendas, regulatory information, progress reports, and publications to SPORE faculty and staff. We will coordinate bi-monthly working group meetings, monthly SPORE Steering Committee meetings, and an annual retreat to facilitate exchange of ideas and use of shared resources. We will coordinate the External Advisory Board and Internal Advisory Board. We will maintain a dedicated website to provide progress updates and contact information, distribute quarterly updates to investigators highlighting resources available through the Biospecimen (Core B) and Biostatistics & Bioinformatics (Core C) Cores, and facilitate bidirectional flow of biospecimen samples and information. This core will also provide administrative oversight of multi-institution SPORE clinical trials. Aim 2: Provide administrative and fiscal oversight and support for all SPORE components. We will interact with Washington University's Grants and Contracts Office and National Cancer Institute staff to prepare and submit annual progress reports and complete other projects as needed. Aim 3: Coordinate the SPORE Developmental Research Program and Career Enhancement Program administrative activities. This core will solicit applications and coordinate review for the Career Enhancement Program (CEP) and Developmental Research Program (DRP). This core will monitor awardee progress, coordinate awardees’ travel to peer SPORE institutions, and facilitate use of core resources by awardees. Aim 4: Enhance participation of underrepresented minorities in all SPORE activities. The Core will oversee DRP and CEP initiatives to promote minority participation in SPORE clinical trials and pancreatic cancer research. We will accomplish this through leadership, community outreach and education, clinical services, clinical trial accrual auditing, support of disparities research, retention and recruitment of minorities, and communication with institutional disparities resources. Aim 5: Ensure advocacy issues are addressed in all aspects of research with patient participants. The Core will ensure that all SPORE components properly incorporate advocacy issues or concerns. We will accomplish this in two ways including patient advocacy and patient feedback. Aim 6: Assist investigators in preparing scholarly presentations, publications, regulatory documents, and all other SPORE-related products. This core will be responsible for completing documentation required for investigators presenting at local and national meetings and submitting of documents to institutional regulatory bodies (e.g., human and animal studies protocols), publications, and final peer-reviewed manuscripts supported by SPORE funds to PubMed Central immediately upon acceptance.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WILLIAM G HAWKINS其他文献

WILLIAM G HAWKINS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WILLIAM G HAWKINS', 18)}}的其他基金

Project 2: Mechanisms of Resistance to Neoantigen Vaccines in PDAC
项目2:PDAC新抗原疫苗耐药机制
  • 批准号:
    10708575
  • 财政年份:
    2023
  • 资助金额:
    $ 13.13万
  • 项目类别:
Preclinical development of the novel inhibitor of apoptosis proteins S2/IAPinh for cancer therapy
用于癌症治疗的新型凋亡蛋白抑制剂 S2/IAPinh 的临床前开发
  • 批准号:
    10568409
  • 财政年份:
    2022
  • 资助金额:
    $ 13.13万
  • 项目类别:
Preclinical Development of ACXT-3102 for the Treatment of Pancreatic Adenocarcinoma (PDAC)
ACXT-3102 治疗胰腺癌 (PDAC) 的临床前开发
  • 批准号:
    10435565
  • 财政年份:
    2019
  • 资助金额:
    $ 13.13万
  • 项目类别:
Preclinical Development of ACXT-3102 for the Treatment of Pancreatic Adenocarcinoma (PDAC)
ACXT-3102 治疗胰腺癌 (PDAC) 的临床前开发
  • 批准号:
    10251498
  • 财政年份:
    2019
  • 资助金额:
    $ 13.13万
  • 项目类别:
Washington University SPORE in Pancreatic Cancer
华盛顿大学 SPORE 在胰腺癌中的应用
  • 批准号:
    9982223
  • 财政年份:
    2016
  • 资助金额:
    $ 13.13万
  • 项目类别:
Washington University SPORE in Pancreatic Cancer
华盛顿大学 SPORE 在胰腺癌中的应用
  • 批准号:
    9146190
  • 财政年份:
    2016
  • 资助金额:
    $ 13.13万
  • 项目类别:
SIGMA-2/PEPTIDOMIMETIC CONJUGATES TARGET APOPTOSIS IN PANCREATIC CANCER
SIGMA-2/拟肽结合物靶向胰腺癌中的细胞凋亡
  • 批准号:
    8630870
  • 财政年份:
    2012
  • 资助金额:
    $ 13.13万
  • 项目类别:
SIGMA-2/PEPTIDOMIMETIC CONJUGATES TARGET APOPTOSIS IN PANCREATIC CANCER
SIGMA-2/拟肽结合物靶向胰腺癌中的细胞凋亡
  • 批准号:
    8219912
  • 财政年份:
    2012
  • 资助金额:
    $ 13.13万
  • 项目类别:
SIGMA-2/PEPTIDOMIMETIC CONJUGATES TARGET APOPTOSIS IN PANCREATIC CANCER
SIGMA-2/拟肽结合物靶向胰腺癌中的细胞凋亡
  • 批准号:
    8463148
  • 财政年份:
    2012
  • 资助金额:
    $ 13.13万
  • 项目类别:
SIGMA-2/PEPTIDOMIMETIC CONJUGATES TARGET APOPTOSIS IN PANCREATIC CANCER
SIGMA-2/拟肽结合物靶向胰腺癌中的细胞凋亡
  • 批准号:
    8879063
  • 财政年份:
    2012
  • 资助金额:
    $ 13.13万
  • 项目类别:

相似海外基金

Transfer Advocacy Groups: Transforming Culture to Support Community College Transfer Students of Color in Undergraduate Physics
转学倡导团体:转变文化以支持社区学院本科物理有色人种转学生
  • 批准号:
    2224295
  • 财政年份:
    2023
  • 资助金额:
    $ 13.13万
  • 项目类别:
    Continuing Grant
Engaging adolescents for sexual and reproductive health and rights and family planning advocacy in Pakistan.
让巴基斯坦青少年参与性健康和生殖健康及权利以及计划生育宣传。
  • 批准号:
    490127
  • 财政年份:
    2023
  • 资助金额:
    $ 13.13万
  • 项目类别:
    Operating Grants
Developing a network for mutual learning on the potential of creative arts for mental health advocacy and activism in Ghana and Indonesia
建立一个网络,以相互学习创意艺术在加纳和印度尼西亚促进心理健康倡导和行动的潜力
  • 批准号:
    AH/X009637/1
  • 财政年份:
    2023
  • 资助金额:
    $ 13.13万
  • 项目类别:
    Research Grant
Protection without Advocacy: Japan's Failure to Support Persons with Mental Disabilities in the community
没有倡导的保护:日本未能支持社区中的精神残疾人
  • 批准号:
    23K01937
  • 财政年份:
    2023
  • 资助金额:
    $ 13.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Developing a cultural adaptation framework for youth mental health education and advocacy initiatives at Jack.org
Jack.org 为青少年心理健康教育和宣传活动制定文化适应框架
  • 批准号:
    484618
  • 财政年份:
    2023
  • 资助金额:
    $ 13.13万
  • 项目类别:
    Fellowship Programs
8th International RASopathies Symposium: Expanding Research and Care Practice through Global Collaboration and Advocacy
第八届国际 RASopathies 研讨会:通过全球合作和宣传扩大研究和护理实践
  • 批准号:
    10683644
  • 财政年份:
    2023
  • 资助金额:
    $ 13.13万
  • 项目类别:
Lupus and health information: Evidence-informed advocacy in action
狼疮和健康信息:循证宣传在行动
  • 批准号:
    485670
  • 财政年份:
    2023
  • 资助金额:
    $ 13.13万
  • 项目类别:
    Miscellaneous Programs
Initiating Meaningful Partnerships for Advocacy and Collaborative Training: The IMPACT initiative
发起有意义的倡导和协作培训伙伴关系:IMPACT 倡议
  • 批准号:
    487847
  • 财政年份:
    2023
  • 资助金额:
    $ 13.13万
  • 项目类别:
    Miscellaneous Programs
Creating advocacy and tech to make secondhand first choice.
创造宣传和技术,让二手货成为首选。
  • 批准号:
    10064859
  • 财政年份:
    2023
  • 资助金额:
    $ 13.13万
  • 项目类别:
    Collaborative R&D
Advocacy Strategies supporting Social Determinants of Health: Paving the Path to Community Reintegration and Recovery
支持健康问题社会决定因素的倡导策略:为社区重新融入和恢复铺平道路
  • 批准号:
    480718
  • 财政年份:
    2023
  • 资助金额:
    $ 13.13万
  • 项目类别:
    Miscellaneous Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了